Broadfin Capital’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-289,035
Closed -$6.28M 53
2018
Q3
$6.28M Buy
+289,035
New +$6.42M 0.92% 32
2018
Q2
Sell
-911,707
Closed -$15.7M 48
2018
Q1
$15.7M Sell
911,707
-820,654
-47% -$13.7M 2.45% 16
2017
Q4
$28.8M Sell
1,732,361
-38,579
-2% -$658K 4.71% 8
2017
Q3
$30.3M Buy
1,770,940
+87,688
+5% +$1.47M 4.48% 8
2017
Q2
$27.3M Buy
1,683,252
+217,800
+15% +$3.44M 3.31% 10
2017
Q1
$25.4M Sell
1,465,452
-5,700
-0.4% -$95.3K 3.08% 7
2016
Q4
$24.8M Sell
1,471,152
-1,419,527
-49% -$23.7M 2.76% 11
2016
Q3
$50.7M Sell
2,890,679
-716,603
-20% -$11.6M 4.54% 6
2016
Q2
$51.8M Buy
3,607,282
+1,108,755
+44% +$13.9M 5.04% 4
2016
Q1
$30.7M Hold
2,498,527
2.97% 9
2015
Q4
$30.3M Buy
2,498,527
+100,000
+4% +$1.23M 1.87% 13
2015
Q3
$31.6M Hold
2,398,527
1.76% 10
2015
Q2
$39.3M Hold
2,398,527
2.11% 10
2015
Q1
$42.7M Sell
2,398,527
-272,176
-10% -$5.06M 3.32% 7
2014
Q4
$50.8M Sell
2,670,703
-304,524
-10% -$5.16M 4.41% 6
2014
Q3
$40.8M Buy
2,975,227
+4,717
+0.2% +$67.3K 4.28% 6
2014
Q2
$48.5M Buy
2,970,510
+377,861
+15% +$5.47M 4.73% 3
2014
Q1
$40.8M Buy
2,592,649
+95,600
+4% +$1.56M 3.96% 5
2013
Q4
$42.8M Sell
2,497,049
-329,602
-12% -$5.07M 5.65% 3
2013
Q3
$37.3M Buy
2,826,651
+100,000
+4% +$1.18M 6.62% 2
2013
Q2
$30.8M Buy
+2,726,651
New +$29M 6.02% 4

Other funds holding ANGO

Broadfin Capital's ANGO Position: Q4 2018 in Review

Broadfin Capital sold out of AngioDynamics (ANGO) in Q4 2018, closing a stake of 289,035 shares — an estimated $6.28M sold.

Broadfin Capital first reported a position in ANGO in Q2 2013 and held it in 21 quarters. The position peaked at $51.8M in Q2 2016. 174 funds tracked by Wall St. Rank hold ANGO as of Q4 2018.

  • Broadfin Capital reported no remaining AngioDynamics position as of Q4 2018 after selling out during the quarter.
  • Broadfin Capital sold 289,035 AngioDynamics shares in Q4 2018, an estimated $6.28M.
  • Broadfin Capital first reported a position in AngioDynamics in Q2 2013 and held it in 21 quarters.
  • Broadfin Capital's AngioDynamics position peaked at $51.8M in Q2 2016.
  • 174 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2018.

Based on Broadfin Capital's 13F filing for Q4 2018, filed 14 Feb 2019.